普雷尼松和易布洛芬结合体Janus树枝状体及其抗癌活性
Israel Barajas-Mendoza1, Irving Osiel Castillo-Rodríguez1, Isabel Hernández-Rioja1
1Instituto de Química, Universidad Nacional Autónoma de México, Ciudad Universitaria, Circuito Exterior, Coyoacán C.P. 04510, México D.F., Mexico.
Steroids
|March 10, 2024
概括
新的Janus树枝状体-药物联合体显示出有前途的抗癌活性. 与布洛芬和普得尼松的第二代结合剂与早期版本相比,对癌细胞具有更高的疗效,对健康细胞没有毒性.
科学领域:
- 药用化学 医学化学
- 纳米技术纳米技术
- 在瘤学瘤学.
背景情况:
- 药物输送系统对于向癌症治疗至关重要.
- 超分支的Janus树枝树为药物结合提供了独特的架构.
- 了解药物和链接器对结合活性的影响是必不可少的.
研究的目的:
- 为了合成和描述与ibuprofen和prednisone结合的新型Janus树枝状体.
- 为了评估这些结合物的体外抗癌活性.
- 调查生成,药物类型和链接器对疗效的影响.
主要方法:
- 第一个和第二代Janus树枝状体的合成使用铜 (I) 催化Click亚化-基循环添加.
- 通过特定的链接器,以ibuprofen和prednisone对树突体的功能化.
- 在各种癌细胞系上使用IC50值进行抗癌活性评估.
- 对非癌性COS-7细胞系的细胞毒性评估.
主要成果:
- 成功合成了雅努斯树枝状树脂-药物联合体.
- 第二代结合体的抗癌活性明显高于第一代结合体.
- 结合物的抗癌疗效超过了单独的树突结合物的抗癌疗效.
- 在非癌性COS-7细胞上没有观察到显著的细胞毒性.
结论:
- 雅努斯树枝状物 - 药物合物,特别是第二代普雷尼松 - 布洛芬合物,显示出强大的抗癌活性.
- 这些新型纳米结合物显示出作为有效的抗癌疗法的潜力.
- 这些发现强调了树枝状分子生成和药物选择对于改善治疗结果的重要性.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
118
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
118
Combined Effects of Drugs: Synergism
3.9K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.9K
Dipeptidyl Peptidase 4 Inhibitors
186
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
186
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
163
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
163
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
523
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
523
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K


